Results 241 to 250 of about 180,290 (312)

Symptomatic and Ultrasonographic Improvement in Rheumatoid Arthritis Temporally Associated with Intravenous NAD⁺ Therapy: A Case Report. [PDF]

ACR Open Rheumatol
Itani MR, Farhat A, Abou Yehya N, Ghraizi L, Bou Dargham B.   +4 more
europepmc   +1 more source

Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization. [PDF]

Pharmaceuticals (Basel)
Chenchula S, Srinivasamurthy SK, Vincent V, Thakkar H, Ganguly S, Kayal S, Keerthivasagam S, Ramamoorthy J, Sharma S, Murugadoss K, Singh A, Pushpam D, Mathaiyan J, Jolly B, Scaria V, Gloor Y, Baleydier F, Bakhshi S, Dubashi B, Ansari M, Uppugunduri CRS.   +20 more
europepmc   +1 more source

Childhood-Onset Takayasu Arteritis With Extensive Vascular Involvement: A Four-Decade Follow-Up Case Report. [PDF]

Case Rep Rheumatol
Djumaeva N, Achundjanova G, Djumaeva L.
europepmc   +1 more source

Reduced IgM natural autoantibody levels against heat shock proteins are associated with disease severity in juvenile idiopathic arthritis. [PDF]

Front Immunol
Mosdósi B, Mátis V, Győri Á, Peti P, Erdő-Bonyár S, Berki T, Simon D.   +6 more
europepmc   +1 more source

Case Report: Hemophagocytic lymphohistiocytosis secondary to <i>Escherichia coli</i> infiltration of bone marrow in a patient with seronegative rheumatoid arthritis treated with low-dose methotrexate. [PDF]

Front Immunol
Liu Z, Li F, Liu Y, Chen X.
europepmc   +1 more source

Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis. [PDF]

J Clin Oncol
Wilson MR, Lewis KL, Kirkwood AA, Cwynarski K, Cheah CY, El-Galaly TC, Villa D, Savage KJ, Ghione P, Bobillo S, Smedby KE, Harrysson S, Trneny M, Klanova M, Puckrin R, Fox CP, Bishton M, Thanarajasingam G, Doo NW, Hapgood G, Soussain C, Choquet S, Dickinson M, Talaulikar D, de Mel S, Preston G, Ahearne M, Hawkes EA, Schorb E, Clavert A, Ku M, Guidetti A, Narkhede M, Calimeri T, Durot E, Smith J, Renaud L, McKay P, Eyre TA.   +38 more
europepmc   +1 more source

Under the Surface: A Rare Case of the En Coup De Sabre Subtype of Linear Morphea in the Rio Grande Valley. [PDF]

Cureus
Lopez M, Hensley J, Villegas M.
europepmc   +1 more source

Hair loss in pediatric inflammatory bowel disease: Clinical recognition and implications for care

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Angela Anaeme, Liza Siegel, Meryl Perlman   +2 more
wiley   +1 more source

Leflunomide and methotrexate

Current Opinion in Rheumatology, 2001
Methotrexate and leflunomide are both effective drugs in the treatment of patients with rheumatoid arthritis. Methotrexate has been available for many years, whereas leflunomide is a relatively new drug. Several large trials describing its efficacy and safety in comparison with both sulfasalazine and methotrexate and with placebo have been published ...
Laan, R.F.J.M., Riel, P.L.C.M. van, Putte, L.B.A. van de   +2 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of Methotrexate and 7-Hydroxy-Methotrexate After Methotrexate Infusions

Cancer Drug Delivery, 1987
Methotrexate was administered by IV infusion, 2g (1.19 +/- 0.05 g/m2) over 24 hours, to a homogeneous group of patients undergoing treatment for breast cancer. Three courses were given at three week intervals. Methotrexate and 7-hydroxy-methotrexate plasma and urine pharmacokinetics were investigated. The average terminal half-lives of methotrexate and
P, Bore, A, Iliadis, J, Catalin, S, Just, J P, Cano   +4 more
openaire   +2 more sources